High Flexibility, Low Cost, High Strength, Good Lubricity, And Easy Handling Of Sol Gel To Create Enormous Growth Opportunity For The Sol Gel Nanocoating Market

 

Sol Gel Nanocoating Market

Sol gel nanocoating is considered a new and advanced nanotechnology that uses sol beads to coat stainless steel and other metal surfaces. Sol gel is basically a mixture of insoluble and soluble materials. It can be used as a coating for metals and other solid materials to protect them from corrosion, wear, tear, damage, corrosion, weathering, termites, and other related damages. Sol Nanoecution is basically the formation of electrically charged spherical composite particles having different sizes ranging from as small as nanometers to as large as 100 micrometers using various chemical processes.

Coatings using sol-gels have become an inevitable part of industrial and domestic activities. They offer a broad range of features including high flexibility, low cost, high strength, good lubricity, and easy handling. Coatings using sol-gels have now become one of the highly recommended solutions for nanostructured protective coatings, protecting the structure against corrosion, weathering, and crushing. Sol gel nanocoatings has come to be the most widely used nanotechnology coatings, as they provide the best advantages and benefits.

The growing focus of manufacturers for developing multi-functional coatings that offer a wide range of properties is a prime factor driving the growth of the Sol gel nanocoating Market. It helps in improving surface energy modification, increase scratch resistance, high abrasion resistance, enhance moisture control, and photocatalytics of the polymers, metallic, papers, ceramic, wood, and fibers materials. Increasing demand for Sol gel nanocoating market for end-user industries such as aerospace and aviation, automotive, and medical industries is again anticipated to foster the growth of the Sol gel nanocoating Market. This coating helps in smoothening of surfaces and reduce manufacturing cost. Furthermore, the growing demand for these coatings across the healthcare industry as it reduces germ concentration and adhesion on medical devices is further anticipated to foster market growth.

North America is projected to gain significant growth over the forecast period and this is attributed to the increasing demand for sol gel nanocoating from end-user industries such as medical devices, automotive, and electrical & electronics industries. Moreover, the increasing implementation of strict VOC emissions regulations that restrict the use of solvent-based coatings is again projected to augment the growth of the sol gel nanocoating market. For instance, the U.S. EPA regulates VOCs at the Federal level in 40 CFR 59, which is the National Volatile Organic Compound Emission Standards for Consumer and Commercial Products such as Aerosol Coatings, Architectural Coatings, etc.

Key Players:

Inframat Corporation, Bio-Gate AG, Cima NanoTech Inc., Buhler PARTEC GmbH, and Eikos Inc. are some of the key players active in the Sol gel nanocoating market

Location: United States

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more